Role of nitric oxide and free radicals in cardioprotection by blocking Na+/H+ and Na+/Ca2+ exchange in rat heart

European Journal of Pharmacology

Volumn 461, Issue 2-3, 2003, Pages 139-147

  Ma̧czewski, Michal ^a   Berȩsewicz, Andrzej ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Cariporide; Free radical; Heart, isolated, rat; Ischemia reperfusion injury; KB R7943; Na1 Ca21 exchange; Na1 H1 exchange; Nitric oxide (NO)

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; CALCIUM ION; CARIPORIDE; FREE RADICAL; HYDROXYL RADICAL; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PROTON; SALICYLIC ACID; SODIUM ION;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM CALCIUM EXCHANGE;

EID: 0037436058     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01302-5     Document Type: Article

References (49)

1. + exchange in ischemia, reperfusion and preconditioning. Cardiovasc. Res. 50:2001;162-166.
2. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 40:1996;C1424-C1437.
3. Beny J.L. Electrical coupling between smooth muscle cells and endothelial cells in pig coronary arteries. Pflugers Arch. 433:1997;364-367.
4. +-glucose cotransporter. J. Cell. Biochem. 84:2001;115-131.
5. Bernier M., Manning A.S., Hearse D.J. Reperfusion arrhythmias: dose-related protection by anti-free radical interventions. Am. J. Physiol. 256:1989;H1344-H1352.
6. Bolli R. Causative role of oxyradicals in myocardial stunning: a proven hypothesis - a brief review of the evidence demonstrating a major role of reactive oxygen species in several forms of postischemic dysfunction. Basic Res. Cardiol. 93:1998;156-162.
7. Brovkovych V., Kalinowski L., Muller-Peddinghaus R., Malinski T. Synergistic antihypertensive effects of nifedipine on endothelium: concurrent release of NO and scavenging of superoxide. Hypertension. 37:2001;34-39.
8. Dawn B., Bolli R. Role of nitric oxide in myocardial preconditioning. Ann. N.Y. Acad. Sci. 962:2002;18-41.
9. Dora K.A., Doyle M.P., Duling B.R. Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles. Proc. Natl. Acad. Sci. U. S. A. 94:1997;6529-6534.
10. Ferdinandy P., Schulz R. Peroxynitrite: toxic or protective in the heart? Circ. Res. 88:2001;E12-E13.
11. Floyd R.A., Watson J.J., Wong P.K. Sensitive assay of hydroxyl radical formation utilizing high-pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J. Biochem. Biophys. Methods. 10:1984;221-235.
12. Frantseva M.V., Velazquez J.L., Hwang P.A., Carlen P.L. Free radical production correlates with cell death in an in vitro model of epilepsy. Eur. J. Neurosci. 12:2000;1431-1439.
13. Gill R.K., Saksena S., Syed I.A., Tyagi S., Alrefai W.A., Malakooti J., Ramaswamy K., Dudeja P.K. Regulation of NHE3 by nitric oxide in caco-2 cells. Am. J. Physiol. 283:2002;G747-G756.
14. Govers R., Rabelink T.J. Cellular regulation of endothelial nitric oxide synthase. Am. J. Physiol. 280:2001;F193-F206.
15. Guarnieri C., Muscario C., Ferrari D., Giordano E., Calderera C.M. Does calcium-driven mitochondrial oxygen free radical formation play a role in cardiac stunning? Basic Res. Cardiol. 92(Suppl. 2):1997;23-25.
16. + exchange inhibition prevents endothelial dysfunction after I/R injury. Am. J. Physiol. 281:2001;H1260-H1266.
17. Halliwell B., Gutteridge J.M.C. Oxygen free radicals and iron in relation to biology and medicine. Some problems and concepts. Arch. Biochem. Biophys. 246:1986;501-514.
18. Ingelman-Sundberg M., Kaur H., Terelius Y., Persson J.O., Halliwell B. Hydroxylation of salicylate by microsomal fractions and cytochrome P-450. Lack of production of 2,3-dihydroxybenzoate unless hydroxyl radical formation is permitted. Biochem. J. 276:1991;753-757.
19. Jones S.P., Girod W.G., Palazzo A.J., Granger D.N., Grisham M.B., Jourd'Heuil D., Huang P.L., Lefer D.J. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am. J. Physiol. 276:1999;H1567-H1573.
20. 2+ exchanger in arteries: identification by immunoblotting and immunofluorescence microscopy. Am. J. Physiol. 266:1994;C234-C242.
21. + exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs. 61:2001;375-389.
22. Karwatowska-Prokopczuk E., Czarnowska E., Beresewicz A. Iron availability and free radical induced injury in isolated ischemic/reperfused rat heart. Cardiovasc. Res. 26:1992;1-9.
23. Kaur H., Whiteman M., Halliwell B. Peroxynitrite-dependent aromatic hydroxylation and nitration of salicylate and phenylalanine. Is hydroxyl radical involved? Free Radic. Res. 26:1997;71-82.
24. 2+ exchanger. Am. J. Physiol. 276:1999;H1868-H1876.
25. 2+ overload in endothelial cells exposed to simulated ischemia. Cardiovasc. Res. 47:2000;394-403.
26. Lefer D.J., Nakanishi K., Johnston W.E., Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation. 88:1993;2337-2350.
27. Maczewski M., Beresewicz A. The role of endothelin, protein kinase C, and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts. J. Mol. Cell. Cardiol. 32:2000;297-310.
28. Mori E., Haramaki N., Ikeda H., Imaizumi T. Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs. Cardiovasc. Res. 40:1998;113-123.
29. Node K., Kitakaze M., Kosaka H., Komamura K., Minamino T., Tada M., Inoue M., Hori M., Kamada T. Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem. Biophys. Res. Commun. 211:1995;370-374.
30. Onodera T., Ashraf M. Detection of hydroxyl-radical in the post-ischemic reperfused heart using salicylate as a trapping agent. J. Mol. Cell. Cardiol. 23:1991;365-370.
31. Piper H.M., Garcia-Dorado D., Ovize M. A fresh look at reperfusion injury. Cardiovasc. Res. 38:1998;291-300.
32. 2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc. Res. 51:2001;241-250.
33. Sekili S., McCay P.B., Li X.Y., Zughaib M., Sun J.Z., Tang L., Thornby J.I., Bolli R. Direct evidence that the hydroxyl radical plays a pathogenetic role in myocardial stunning in the conscious dog and demonstration that stunning can be markedly attenuated without subsequent adverse effects. Circ. Res. 73:1993;705-723.
34. + exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation. 96:1997;3617-3625.
35. Siegfried M.R., Erhardt J., Rider T., Ma X.-L., Lefer A.M. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J. Pharmacol. Exp. Ther. 260:1992;668-675.
36. Sun J.-Z., Kaur H., Halliwell B., Li X.-Y., Bolli R. Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo. Direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. Circ. Res. 73:1993;534-549.
37. 2+-dependent activation of endothelial nitric-oxide synthase. J. Biol. Chem. 274:1999;29529-29535.
38. Theroux P., Chaitman B.R., Danchin N., Erhardt L., Meinertz T., Schroeder J.S., Tognoni G., White H.D., Willerson J.T., Jessel A. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) investigators. Circulation. 102:2000;3032-3038.
39. Tosaki A., Maulik N., Elliott G.T., Blasig I.E., Engelman R.M., Das D.K. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. J. Pharmacol. Exp. Ther. 285:1998;1274-1279.
40. + with dioxygen; comparison with the Fenton chemistry. Acta Biochim. Pol. 47:2000;951-962.
41. Vinten-Johansen J. Physiological effects of peroxynitrite: potential products of the environment. Circ. Res. 87:2000;170-172.
42. Wang P.H., Zweier J.L. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart-evidence for peroxynitrite-mediated reperfusion injury. J. Biol. Chem. 271:1996;29223-29230.
43. Weiland U., Haendeler J., Ihling C., Albus U., Scholz W., Ruetten H., Zeiher A.M., Dimmeler S. Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cardiovasc. Res. 45:2000;671-678.
44. Weyrich A.S., Ma X.-L., Lefer A.M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 86:1992;279-288.
45. Yang B.C., Mehta J.L. Inhibition of nitric oxide does not affect reperfusion-induced myocardial injury, but it prevents lipid peroxidation in the isolated rat heart. Life Sci. 61:1997;229-236.
46. Yasmin W., Strynadka K.D., Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc. Res. 33:1997;422-432.
47. + exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J. Am. Coll. Cardiol. 38:2001;1644-1650.
48. Zhang H.Y., McPherson B.C., Liu H.P., Baman T., McPherson S.S., Rock P., Yao Z.H. Role of nitric-oxide synthase, free radicals, and protein kinase C delta in opioid-induced cardioprotection. J. Pharmacol. Exp. Ther. 301:2002;1012-1019.
49. Zweier J.L., Flaherty J.T., Weisfeldt M.L. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc. Natl. Acad. Sci. U. S. A. 84:1987;1404-1407.